Pazda Magdalena, Stepnowski Piotr, Sledzinski Tomasz, Chmielewski Michal, Mika Adriana
Department of Environmental Analysis, Faculty of Chemistry, University of Gdansk, Poland.
Department of Pharmaceutical Biochemistry, Medical University of Gdansk, Poland.
Biomed Chromatogr. 2017 Nov;31(11). doi: 10.1002/bmc.4006. Epub 2017 Jun 15.
Gas chromatography-mass spectrometry is a preferred method for fatty acid (FA) analysis in biofluids from patients with metabolic diseases. Complex characteristics of FAs make their analysis particularly challenging. Selection of an appropriate chromatographic column is particularly important component of the process as it provides optimal separation and detection of possibly all FAs present in the sample. However, no accurate protocol for comparative evaluation of capillary columns for the analysis of whole serum FA profile in patients with chronic kidney disease (CKD) has been developed thus far. Therefore, in the present study four columns were examined to select the one providing optimal separation and determination of FA profiles in this group of patients. Moreover, serum FA profiles obtained with the selected column in CKD patients subjected to peritoneal dialysis and healthy controls were compared. Thirty-seven component FAME Mix and sera from CKD patients were used to optimize chromatographic conditions and to select the most appropriate column. The ZB-5 column turned out to be the most appropriate for the analysis of whole FA profile in CKD patients' sera. Then, this column was used to compare FA profiles in patients subjected to peritoneal dialysis and in healthy controls. The analysis demonstrated many abnormalities in the FA profile of CKD patients. Further studies involving larger groups of patients presenting with other stages of CKD are required to explain the impact of the disease progression on composition of serum FAs.
气相色谱 - 质谱联用是分析代谢疾病患者生物流体中脂肪酸(FA)的首选方法。脂肪酸的复杂特性使其分析极具挑战性。选择合适的色谱柱是该过程中特别重要的组成部分,因为它能对样品中可能存在的所有脂肪酸进行最佳分离和检测。然而,迄今为止,尚未开发出用于比较评估慢性肾脏病(CKD)患者全血清脂肪酸谱的毛细管柱的准确方案。因此,在本研究中,对四根色谱柱进行了检测,以选择能为该组患者提供最佳脂肪酸谱分离和测定的柱子。此外,还比较了在接受腹膜透析的CKD患者和健康对照中,使用所选色谱柱获得的血清脂肪酸谱。使用37种组分的脂肪酸甲酯混合物和CKD患者的血清来优化色谱条件并选择最合适的色谱柱。结果表明,ZB - 5柱最适合分析CKD患者血清中的全脂肪酸谱。然后,使用该柱比较接受腹膜透析的患者和健康对照的脂肪酸谱。分析表明,CKD患者的脂肪酸谱存在许多异常。需要进一步开展涉及更多处于CKD其他阶段患者的研究,以解释疾病进展对血清脂肪酸组成的影响。